Chemoinformaics analysis of 1-O-Formylmethyl rocaglate
| Molecular Weight | 520.534 | nRot | 8 |
| Heavy Atom Molecular Weight | 492.31 | nRig | 28 |
| Exact Molecular Weight | 520.173 | nRing | 5 |
| Solubility: LogS | -5.017 | nHRing | 1 |
| Solubility: LogP | 3.712 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 3 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 18 |
| nHA | 9 | APOL | 74.3182 |
| nHD | 1 | BPOL | 40.2418 |
| QED | 0.353 |
| Synth | 4.163 |
| Natural Product Likeliness | 1.542 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.815 |
| Pgp-sub | 0.002 |
| HIA | 0.011 |
| CACO-2 | -5.189 |
| MDCK | 0.0000409 |
| BBB | 0.852 |
| PPB | 0.814655 |
| VDSS | 1.924 |
| FU | 0.106344 |
| CYP1A2-inh | 0.068 |
| CYP1A2-sub | 0.779 |
| CYP2c19-inh | 0.868 |
| CYP2c19-sub | 0.778 |
| CYP2c9-inh | 0.886 |
| CYP2c9-sub | 0.577 |
| CYP2d6-inh | 0.259 |
| CYP2d6-sub | 0.879 |
| CYP3a4-inh | 0.977 |
| CYP3a4-sub | 0.899 |
| CL | 8.826 |
| T12 | 0.164 |
| hERG | 0.278 |
| Ames | 0.785 |
| ROA | 0.602 |
| SkinSen | 0.025 |
| Carcinogencity | 0.311 |
| EI | 0.012 |
| Respiratory | 0.774 |
| NR-Aromatase | 0.89 |
| Antiviral | Yes |
| Prediction | 0.901869 |